Indeed, expression of IL-1β and TNF-α, known to modulate blood–brain barrier permeability51 was significantly decreased in the brains of both lipopeptide pre-treated and post-treated mice, suggesting that peptide treatment reduced SARS-CoV-2 entry into the brain at the later stages of infection and decreased consequent lethality. Here, IL1B is linked to infection.